The Uromigos
The Uromigos
Broadcasting the latest developments in GU cancerHosted by Brian Rini and Tom Powles Brian Rini MD is an Ingram Professor of Medicine (Hematology/Oncology), Vanderbilt-Ingram Cancer CenterTom Powles is the Director of Barts Cancer Centre, St Bartholomew's Hospital and Professor of Genitourinary Oncology, Queen Mary University of London
Be sure to visit the podcast's website and support the creator: www.uromigos.org
Where to listen?
Podcasts in the app Replaio Radio Coming soonPodcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts
Episodes
Episode 111: The randomised phase 3 CANTATA in metastatic renal cancer 08.06.2021 29:03
Nizar Tannir describes the results of this trial with a novel glutaminase inhibitor.
Episode 110: PEACE1 - Triplet therapy in prostate cancer 08.06.2021 27:51
Karim Fizazi describes the results of this randomised, potentially practice-changing trial.
Episode 109: Adjuvant pembrolizumab in renal cancer 07.06.2021 30:45
Toni Choueiri describes the KN564 study in detail.
Episode 108: Peter O'Donnell gives five year follow-up data on front line pembrolizumab in urothelial cancer 07.06.2021 24:09
Tom and Peter continue to see things differently - has the data changed things?
Episode 107: ASCO 2021: Neoadjuvant chemo/nivolumab as bladder sparing 07.06.2021 16:48
Matt Galsky describes his Phase 2 study and gives a vision of the future.
Episode 106: Summary of the three bladder sparing neoadjuvant trials at ASCO 2021 07.06.2021 26:01
Andrea Necchi gives a summary of the three abstracts.
Episode 105: A Phase 2 study of novel immune combinations (ICOS) in bladder cancer 07.06.2021 19:38
Arjun Balar discusses this and his neoadjuvant chemo/immune/RT trial.
Episode 104: Plenary Session 177lu-PSMA-617 in Prostate Cancer 06.06.2021 30:29
Mike Morris does his stuff.
Episode 103: Targeting the microbiome to increase the activity of immune therapy in renal cancer 06.06.2021 13:31
Monty Pal describes a small randomised trial of ipi/nivo plus CMB588.
Episode 102: Adjuvant therapy in melanoma - how it will help inform the renal community 28.05.2021 29:05
James Larkin describes learning from adjuvant immune checkpoint inhibitors in melanoma.
Episode 101: The Uromigos Paper of the Month - Belzutifan in renal cancer 26.05.2021 26:59
Eric Jonasch gives an overview of the recent Nature Medicine publication.
Episode 100: The Uromigos 100th Podcast - Looking to the Future 21.05.2021 36:24
Chris Sweeney, Kala Sridhar and David McDermott discuss the future.
Episode 99: Navigating social media from a patients' perspective 19.05.2021 24:58
Dena Battle is the co-founder and president of KCure and a passionate kidney cancer patient advocate.
Episode 98: Bladder cancer from a patient perspective 19.05.2021 23:35
Dr. Lydia Makaroff, Vice President of the World Bladder Cancer Patient Coalition, discusses key issues for bladder cancer.
Episode 97: Sacituzumab Govitecan in Bladder Cancer 04.05.2021 18:21
Petros Grivas discusses the recent accelerated approval and JCO paper data.
Episode 96: ODAC Bladder Cancer Accelerated Approval Meetings with Andrea Apolo 28.04.2021 26:23
Andrea Apolo discusses highlights from the April 28th meeting.
Episode 95: ODAC Overview and Bladder Accelerated Approval Meetings with Jorge Garcia 28.04.2021 26:55
Jorge Garcia discusses the pembrolizumab and atezolizumab bladder cancer dangling accelerated approvals and the ODAC process
Episode 94: EIKCS Summary of Day 1 23.04.2021 24:40
Samra Turajlic summarised the meetings and looks forward to Day 2...
Episode 93: The Uromigos Paper of the Month - A new risk classification for germ cell cancer 14.04.2021 23:49
Silke Gillessen discusses the back to back JCO papers on this topic.
Episode 92: Second line therapy in advanced RCC 09.04.2021 27:31
Viktor Grünwald discusses treatment for progression of disease after front lines PD1 based therapy.
Episode 91: The Uromigos Paper of the Month - Adjuvant atezolizumab in bladder cancer 26.03.2021 29:05
Joaquim Bellmunt describes this study as well as adjuvant nivolumab and ctDNA in bladder cancer.
Episode 90: The Uromigos Podcast with QOL Expert David Cella 12.03.2021 27:46
Everything you wanted to know about quality of life assessment in cancer but were too afraid to ask.
Episode 89: The Uromigos Paper of the Month - Pembrolizumab in clear cell and non-clear cell renal cancer 04.03.2021 28:14
David McDermott describes these back to back JCO publications.
Episode 88: Career Development in Academic Oncology Part 3 - Walter Stadler 26.02.2021 23:14
In these podcasts, we explore academic career development with individuals in different stages of their career.
Episode 87: Career Development in Academic Oncology Part 2 - Monty Pal 26.02.2021 22:17
In these podcasts, we explore academic career development with individuals at different stages in their career.
Similar podcasts
Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.